| Primary |
| Atrial Fibrillation |
25.3% |
| Cardiac Disorder |
18.7% |
| Cardiac Failure Congestive |
11.8% |
| Product Used For Unknown Indication |
9.1% |
| Arrhythmia |
7.7% |
| Heart Rate Irregular |
6.0% |
| Drug Use For Unknown Indication |
5.0% |
| Cardiac Failure |
4.6% |
| Hypertension |
2.4% |
| Heart Rate Increased |
1.3% |
| Cardiac Failure Chronic |
1.2% |
| Myocardial Infarction |
1.0% |
| Supraventricular Tachycardia |
0.9% |
| Atrial Flutter |
0.9% |
| Cardiomyopathy |
0.8% |
| Coronary Artery Disease |
0.8% |
| Tachycardia Foetal |
0.8% |
| Tachycardia |
0.7% |
| Palpitations |
0.7% |
| Cardiac Operation |
0.5% |
|
| Vomiting |
14.5% |
| Therapeutic Agent Toxicity |
12.7% |
| Death |
9.2% |
| Unevaluable Event |
8.4% |
| Weight Decreased |
8.1% |
| Pain |
6.4% |
| Multiple Injuries |
4.4% |
| Injury |
3.6% |
| Pharmaceutical Product Complaint |
3.4% |
| Nausea |
3.3% |
| Surgery |
3.3% |
| Weight Increased |
3.3% |
| Urinary Tract Infection |
2.7% |
| Ventricular Tachycardia |
2.7% |
| Vision Blurred |
2.7% |
| Myocardial Infarction |
2.6% |
| Renal Failure |
2.5% |
| Visual Impairment |
2.4% |
| Toxicity To Various Agents |
2.0% |
| Ventricular Fibrillation |
1.9% |
|
| Secondary |
| Product Used For Unknown Indication |
23.4% |
| Atrial Fibrillation |
20.0% |
| Drug Use For Unknown Indication |
18.7% |
| Cardiac Failure |
7.0% |
| Hypertension |
7.0% |
| Cardiac Failure Congestive |
4.5% |
| Arrhythmia |
2.6% |
| Cardiac Disorder |
2.4% |
| Chronic Obstructive Pulmonary Disease |
1.8% |
| Atrial Flutter |
1.7% |
| Type 2 Diabetes Mellitus |
1.4% |
| Depression |
1.4% |
| Ill-defined Disorder |
1.4% |
| Diabetes Mellitus |
1.3% |
| Thrombosis Prophylaxis |
1.2% |
| Hypokalaemia |
1.0% |
| Supraventricular Tachycardia |
0.9% |
| Pulmonary Hypertension |
0.8% |
| Emphysema |
0.7% |
| Heart Rate Irregular |
0.7% |
|
| Vomiting |
15.6% |
| Weight Decreased |
12.2% |
| Therapeutic Agent Toxicity |
12.0% |
| Ventricular Tachycardia |
7.7% |
| Weight Increased |
7.3% |
| Renal Failure |
4.5% |
| Renal Failure Acute |
4.2% |
| Visual Impairment |
3.7% |
| Urinary Tract Infection |
3.6% |
| Syncope |
3.3% |
| Toxicity To Various Agents |
3.3% |
| Unevaluable Event |
2.9% |
| Wheezing |
2.8% |
| Completed Suicide |
2.6% |
| Bradycardia |
2.6% |
| Death |
2.5% |
| Hyperkalaemia |
2.4% |
| Thrombocytopenia |
2.3% |
| Wound Infection |
2.3% |
| Jaundice |
2.2% |
|
| Concomitant |
| Product Used For Unknown Indication |
28.1% |
| Drug Use For Unknown Indication |
20.4% |
| Atrial Fibrillation |
11.9% |
| Hypertension |
7.4% |
| Cardiac Disorder |
3.7% |
| Cardiac Failure |
2.9% |
| Pulmonary Arterial Hypertension |
2.9% |
| Diabetes Mellitus |
2.8% |
| Pain |
2.1% |
| Prophylaxis |
2.1% |
| Cardiac Failure Congestive |
2.0% |
| Rheumatoid Arthritis |
1.9% |
| Chronic Obstructive Pulmonary Disease |
1.8% |
| Blood Cholesterol Increased |
1.8% |
| Depression |
1.6% |
| Osteoporosis |
1.6% |
| Pulmonary Hypertension |
1.5% |
| Multiple Myeloma |
1.4% |
| Type 2 Diabetes Mellitus |
1.3% |
| Anticoagulant Therapy |
1.0% |
|
| Vomiting |
11.0% |
| Death |
9.6% |
| Weight Decreased |
8.5% |
| Pneumonia |
7.3% |
| International Normalised Ratio Increased |
5.6% |
| Renal Failure Acute |
5.4% |
| Dyspnoea |
4.9% |
| Renal Failure |
4.8% |
| Sepsis |
4.3% |
| Oedema Peripheral |
4.1% |
| Thrombocytopenia |
4.0% |
| Urinary Tract Infection |
3.8% |
| Weight Increased |
3.8% |
| Pain |
3.8% |
| Cardiac Failure |
3.6% |
| Nausea |
3.2% |
| Atrial Fibrillation |
3.1% |
| Syncope |
3.1% |
| Cerebrovascular Accident |
3.0% |
| Drug Ineffective |
2.9% |
|
| Interacting |
| Product Used For Unknown Indication |
19.9% |
| Atrial Fibrillation |
17.7% |
| Drug Use For Unknown Indication |
14.9% |
| Hypertension |
8.0% |
| Cardiac Failure |
6.2% |
| Overdose |
4.1% |
| Multiple Drug Overdose |
3.3% |
| Depression |
2.9% |
| Atrial Flutter |
2.7% |
| Diabetes Mellitus |
2.6% |
| Ill-defined Disorder |
2.6% |
| Tachycardia Foetal |
2.4% |
| Cardiac Disorder |
2.2% |
| Hydrops Foetalis |
1.8% |
| Myocardial Ischaemia |
1.7% |
| Pain |
1.7% |
| Arrhythmia |
1.4% |
| Gout |
1.2% |
| Prophylaxis |
1.2% |
| Essential Hypertension |
1.1% |
|
| Drug Interaction |
16.2% |
| Toxicity To Various Agents |
13.4% |
| Therapeutic Agent Toxicity |
11.2% |
| Vomiting |
10.1% |
| Renal Failure |
9.5% |
| Renal Failure Acute |
6.7% |
| Foetal Death |
3.9% |
| Maternal Exposure During Pregnancy |
3.4% |
| Rash |
3.4% |
| Myocardial Infarction |
2.8% |
| Upper Gastrointestinal Haemorrhage |
2.8% |
| Ventricular Extrasystoles |
2.8% |
| Loss Of Consciousness |
2.2% |
| Cardiogenic Shock |
1.7% |
| Dyspnoea |
1.7% |
| Hyperkalaemia |
1.7% |
| Overdose |
1.7% |
| Pain |
1.7% |
| Paralysis |
1.7% |
| Vasculitic Rash |
1.7% |
|
